Postbiotic as Adjunct Treatment for Vaginal Candidiasis

This project aims to study the efficacy of oral administration of postbiotic at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks compared to placebo.

Inclusion criteria * Women who are sexually active * Confirmed with candidiasis as confirmed via clinical observations which include creamy whitish vaginal discharge and vulva-vaginal itchiness * Willing to commit throughout the experiment Exclusion criteria * Long term medication (6 months or more) for any illnesses * Pregnant * Menopaused * Uterus and/or cervix removed * Cervical intraepithelial neoplasia * Vaginal suppository treatments within 4-weeks prior to entering the study * Oral medication for vaginal illnesses or any vaginal therapy such as hormones and estrogen within 4-weeks prior to entering the study * Have used vaginal estrogen cream, ring or tablet within 4-weeks prior to entering the study * Have used vaginal moisturizers, lubricants or homeopathic preparations within 4-weeks prior to entering the study * Have used spermicide agent within 4-weeks prior to entering the study * Have pelvic or any gynecologic surgery 6-months prior to entering the study